What It Feels Like to Wait for a Treatment That Doesn’t Exist
One patient’s journey through rare disease diagnosis, clinical trial participation,…
Clinical Trials Are Complex. Workflows Shouldn’t Make Them Harder.
As clinical trials scale across systems, vendors, countries, and languages,…
How AI Is Changing Multilingual Execution
From AI training data to agentic workflows, multilingual execution is…
Accessibility in Clinical Trials Isn’t Optional. It’s Foundational to Better Recruitment.
Patient recruitment has always been one of the most challenging…
How Specialization Is Reshaping Language Services
Explore how specialization is reshaping how global content gets executed…
Welo Life Sciences: Built for Life Sciences Translation, Regulatory Content, and Global Compliance
This is the environment where life sciences translation, regulatory content…
MDR Reform and the Future of Multilingual Compliance for Medical Device Companies
How documentation strategy, translation risk, and regulatory transparency are evolving…
EMA’s Guiding Principles on LLMs: Reshaping Regulatory Translation
Discover how the EMA’s Guiding Principles on LLMs are transforming…
Creating a Future-Ready Model for a Global MedTech Leader
Discover how a global MedTech leader deployed OPAL Enable to…
How FDA and EMA Shape Linguistic Validation in Clinical Research
As clinical research becomes global, understanding how to meet regulatory…
